{"nctId":"NCT01783886","briefTitle":"Efficacy and Safety of VEGF Trap Eye in Diabetic Macular Edema (DME) With Central Involvement","startDateStruct":{"date":"2013-02"},"conditions":["Macular Edema"],"count":381,"armGroups":[{"label":"Intravitreal Aflibercept Injection 2Q4","type":"EXPERIMENTAL","interventionNames":["Biological: Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)"]},{"label":"Intravitreal Aflibercept Injection 2Q8","type":"EXPERIMENTAL","interventionNames":["Biological: Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)"]},{"label":"Macular Laser Photocoagulation","type":"ACTIVE_COMPARATOR","interventionNames":["Procedure: Macular Laser Photocoagulation"]}],"interventions":[{"name":"Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)","otherNames":[]},{"name":"Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)","otherNames":[]},{"name":"Macular Laser Photocoagulation","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Adults â‰¥ 18 years with type 1 or 2 diabetes mellitus\n* Subjects with diabetic macular edema (DME) secondary to diabetes mellitus involving the center of the macula in the study eye\n* Decrease in vision determined to be primarily the result of DME in the study eye\n* Best-corrected visual acuity (BCVA) early treatment diabetic retinopathy study (ETDRS) letter score of 73 to 24 (20/40 to 20/320) in the study eye\n\nExclusion Criteria:\n\n* Laser photocoagulation (panretinal or macular) in the study eye within 90 days of Day 1\n* More than 2 previous macular laser treatments in the study eye\n* Previous use of intraocular or periocular corticosteroids in the study eye within 120 days of Day 1\n* Previous treatment with antiangiogenic drugs in either eye (pegaptanib sodium, bevacizumab, ranibizumab etc.) within 90 days of Day 1\n* Active proliferative diabetic retinopathy (PDR) in the study eye\n* Uncontrolled diabetes mellitus, as defined by HbA1c \\>12%\n* Only 1 functional eye even if that eye is otherwise eligible for the study","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change From Baseline in Best Corrected Visual Acuity (BCVA) as Measured by Early Treatment Diabetic Retinopathy Study (ETDRS) Letter Score at Week 52 - Last Observation Carried Forward (LOCF)","description":"Visual function of the study eye was assessed using the ETDRS protocol, which is a widely accepted international standard for macular laser photocoagulation treatment. A higher score represents better functioning. LOCF censored measurements after additional treatment.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"13.7","spread":"8.4"},{"groupId":"OG001","value":"12.8","spread":"9.5"},{"groupId":"OG002","value":"-0.2","spread":"13.5"}]}]}]},{"type":"SECONDARY","title":"Percentage of Participants Who Gained at Least 10 Letters in BCVA as Measured by ETDRS Letter Score Compared With Baseline at Week 52 - LOCF","description":"Visual function of the study eye was assessed using the ETDRS protocol. A higher score represents better functioning.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"70.9","spread":null},{"groupId":"OG001","value":"62.7","spread":null},{"groupId":"OG002","value":"23.4","spread":null}]}]}]},{"type":"SECONDARY","title":"Percentage of Participants Who Gained at Least 15 Letters in BCVA as Measured by ETDRS Letter Score Compared With Baseline at Week 52 - LOCF","description":"Visual function of the study eye was assessed using the ETDRS protocol. A higher score represents better functioning.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"43.3","spread":null},{"groupId":"OG001","value":"36.5","spread":null},{"groupId":"OG002","value":"12.1","spread":null}]}]}]},{"type":"SECONDARY","title":"Percentage of Participants With a Greater Than Equal (>=) Two-step Improvement From Baseline in the ETDRS Diabetic Retinopathy Severity Score (DRSS) as Assessed by Fundus Photography (FP) at Week 52 - LOCF","description":"ETDRS DRSS: None (level 10); Mild to moderate nonproliferative diabetic retinopathy (DR) (levels 14, 15, 20, 35, and 43); Moderately severe/severe nonproliferative DR (levels 47 and 53); Mild/moderate/high-risk/advanced proliferative DR (levels 61, 65, 71,75, 81, and 85)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"60.7","spread":null},{"groupId":"OG001","value":"62.3","spread":null},{"groupId":"OG002","value":"21.7","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Central Retinal Thickness (CRT) at Week 52 as Assessed on Optical Coherence Tomography (OCT) - LOCF","description":"CRT was assessed using spectral domain optical coherence tomography (SD-OCT), a non-invasive diagnostic system providing high-resolution imaging sections of the retina. SD-OCT was performed in the study eye after pupil dilation. A negative change from Baseline indicated improvement.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-238.7","spread":"172.5"},{"groupId":"OG001","value":"-234.7","spread":"160.8"},{"groupId":"OG002","value":"-109.3","spread":"206.9"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in National Eye Institute 25-item Visual Function Questionnaire (NEI VFQ-25) Near Activities Subscale at Week 52 - LOCF","description":"The NEI VFQ-25 total score ranges from 0-100 with a score of 0 being the worst outcome and 100 being the best outcome. The NEI VFQ questionnaire is organized as a collection of subscales that are all scored from 0-100. Near activities are defined as reading ordinary print in newspapers, performing work or hobbies requiring near vision, or finding something on a crowded shelf.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.65","spread":"23.86"},{"groupId":"OG001","value":"7.28","spread":"22.95"},{"groupId":"OG002","value":"0.04","spread":"24.39"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in National Eye Institute 25-item Visual Function Questionnaire (NEI VFQ-25) Distance Activities Subscale at Week 52 - LOCF","description":"The NEI VFQ-25 total score ranges from 0-100 with a score of 0 being the worst outcome and 100 being the best outcome. The NEI VFQ questionnaire is organized as a collection of subscales that are all scored from 0-100. Distance activities are defined as reading street signs or names on stores, and going down stairs, steps, or curbs.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.93","spread":"22.36"},{"groupId":"OG001","value":"10.25","spread":"21.44"},{"groupId":"OG002","value":"0.04","spread":"23.14"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":19,"n":127},"commonTop":["Visual acuity reduced","Diabetic retinal oedema","Retinal haemorrhage","Conjunctival haemorrhage","Diabetes mellitus"]}}}